Use of ultrasound to evaluation interstitial lung disease in rheumatic disease by O. B. Ovsyannikova, O. A. Koneva, L. A. Garzanova, L. P. Ananyeva

Get full text

Effect of rituximab on heart involvement in systemic sclerosis by L. A. Garzanova, L. P. Ananyeva, O. A. Koneva, O. B. Ovsyannikova

Get full text

CHANGES OF ACTIVITY INDEX AND TOTAL SEVERITY INDEX IN PATIENTS WITH SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE OVER A 5-YEAR FOLLOW-UP PERIOD by O. B. Ovsyannikova, L. P. Ananyeva, V. N. Lesnyak, O. A. Koneva, M. N. Starovoitova, O. V. Desinova

Get full text

ASSESSMENT OF THE SENSITIVITY OF NEW CRITERIA FOR SYSTEMIC SCLEROSIS IN RUSSIAN PATIENT POPULATION by O. A. Koneva, O. B. Ovsyannikova, M. N. Starovoitova, E. O. Cheremukhina, E. N. Aleksandrova, L. P. Ananyeva

Get full text

CLINICAL EVALUATION OF THE MANIFESTATIONS OF INTERSTITIAL LUNG INJURYIN SYSTEMIC SCLERODERMA FROM HIGH-RESOLUTION COMPUTER T OMOGRAPHY DATA by L P Anan'eva, L V Teplova, V N Lesnyak, O A Koneva, O B Ovsyannikova, M N Starovoytova, O V Desinova, L P Ananyeva, L V Teplova, V N Lesnyak, O A Koneva, O B Ovsyannikova, M N Starovoitova, O V Desinova

Get full text

Renal function during long-term therapy with rituximab in patients with systemic sclerosis by M. N. Starovoitova, O. V. Desinova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova

Get full text

Clinical and laboratory characteristics of patients with systemic sclerosis positive for anti-ribonucleoprotein antibodies by R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N. Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova

Get full text

Characteristics of the new coronavirus infection (COVID-19) in patients with systemic sclerosis by M. N. Starovoytova, O. V. Desinova, L. P. Ananieva, O. A. Koneva, L. А. Garzanova, O. B. Ovsyannikova, R. U. Shayakhmetova

Get full text

Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma by R. U. Shayakhmetova, L. P. Ananyeva, O. A. Koneva, M. N Starovoitova, O. V. Desinova, O. B. Ovsyannikova, L. A. Garzanova

Get full text

Relationship between digital ulcers and severity of lung function test in systemic sclerosis over a five-year period by O. B. Ovsyannikova, O. A. Koneva, L. P. Ananieva, L. A. Garzanova, M. N. Srarovoytova, O. V. Desinova, R. U. Shayakhmetova

Get full text

Safety and tolerability of rituximab in the treatment of systemic sclerosis by L. A. Garzanova, L. P. Ananyeva, O. A. Koneva, O. V. Desinova, M. N. Starovoytova, O. B. Ovsyannikova, R. U. Shayakhmetova, S. I. Glukhova

Get full text

Short-term absolute B-cell counts monitoring in systemic sclerosis patients treated with rituximab by L. P. Ananieva, L. A. Garzanova, O. V. Desinova, O. A. Koneva, M. N. Starovoytova, O. B. Ovsyannikova, A. P. Aleksankn, S. I. Glukhova

Get full text

Profile of autoantibodies in systemic sclerosis by M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, R. T. Alekperov, M. V. Cherkasova, E. N. Aleksandrova, L. P. Ananyeva

Get full text

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 2. Safety and complications by O. B. Ovsyannikova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. V. Desinova, R. U. Shayakhmetova, M. N. Starovoitova, A. M. Lila

Get full text

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 1. Clinical aspects by O. B. Ovsyannikova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, R. U. Shayakhmetova, O. V. Desinova, M. N. Starovoitova, A. M. Lila

Get full text

The use of the Scleroderma Clinical Trials Consortium Damage Index in systemic sclerosis by L. P. Ananyeva, V. V. Babak, A. D. Koltakova, O. A. Koneva, O. V. Desinova, M. N. Starovoytova, O. B. Ovsyannikova, R. U. Shayakhmetova

Get full text

Comparative characteristics of the main phenotypes of systemic sclerosis by R. U. Shayakhmetova, L. P. Ananyeva, M. N. Starovoitova, O. V. Desinova, O. A. Koneva, O. B. Ovsyannikova, L. A. Garzanova, M. V. Cherkasova, R. T. Alekperov

Get full text

The use of “Acellbia” – a biosimilar of rituximab in systemic sclerosis by L. P. Ananyeva, L. A. Garzanova, O. V. Desinova, R. U. Shayakhmetova, M. N. Starovoytova, O. A. Koneva, O. B. Ovsyannikova, S. I. Glukhova, E. L. Nasonov

Get full text

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA by O A Koneva, L P Ananyeva, O B Ovsyannikova, L V Teplova, M N Starovoitova, O V Desinova, T A Nevskaya, R T Alekperov, E G Lyubimova, L N Denisov

Get full text

Effect of rituximab on the manifestations of activity and pulmonary function in patients with systemic sclerosis: one-year follow-up evaluation by L. P. Ananyeva, O. A. Koneva, O. V. Desinova, L. A. Garzanova, S. I. Glukhova, M. N. Starovoitova, O. B. Ovsyannikova, A. V. Volkov, A. P. Aleksankin, E. L. Nasonov

Get full text